clinical trial – Page 216 – Communicable Diseases Research

Understanding COVID-19: From Origin to Potential Therapeutics

Review

Published on 2020-08-142022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS,

[키워드] acute respiratory syndrome addressed agency antiviral drug article carrier caused China clinical feature Clinical features clinical manifestation clinical trial concerning coronavirus Coronavirus-2 COVID-19 COVID-19 infection Cytokine storm death Dexamethasone disease dry cough effective effort Epidemiology Evolution global pandemic globe Government ground-glass opacity high risk human coronavirus Infection information life cycle media MERS middle origin outbreak pandemic pangolins Pathogenesis pathogenicity Patient plethora Pneumonia Potential public health Remdesivir reported Research resource RT-PCR SARS-CoV-2 scientist Septic shock severe respiratory infections sore throat syndrome Therapeutics Treatment understanding Vaccine Vaccines virus
[DOI] 10.3390/ijerph17165904 PMC 바로가기 [Article Type] Review

A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study

Full Paper

Published on 2020-08-132022-10-28
Journal: Advanced Science [Category] COVID-19,

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?

Microbiology

Published on 2020-08-132022-10-31
Journal: Frontiers in Microbiology [Category] COVID-19,

Disease progression of cancer patients during COVID-19 pandemic: a comprehensive analytical strategy by time-dependent modelling

Research Article

Published on 2020-08-122022-10-28
Journal: BMC Medical Research Methodology [Category] Coronavirus, Fulltext, MERS,

Safety of a quadrivalent influenza vaccine in Vietnamese healthy subjects aged 6 months and older

Article

Published on 2020-08-122023-06-23
Journal: Human vaccines & immunotherapeutics [Category] 신종인플루엔자,

[키워드] adverse event Adverse reaction clinical trial influenza vaccine Seasonal influenza Vietnam
[DOI] 10.1080/21645515.2020.1795477 PMC 바로가기

A COVID‐19 human viral challenge model. Learning from experience

Invited Review Article

Published on 2020-08-122022-10-30
Journal: Influenza and Other Respiratory Viruses [Category] COVID-19, MERS, SARS,

Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks

Narrative Review

Published on 2020-08-112022-10-04
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 치료법,

[키워드] acute respiratory syndrome administration adverse events Alter antibody antivirals article benefit candidate clinical Clinical outcome clinical trial content control groups convalescent convalescent patient convalescent plasma coronavirus coronavirus disease Coronavirus-2 Coronaviruses Course COVID-19 Critically ill patient described determine Donor effective Efficacy and safety Evidence feasibility FIVE follow-up time had more high risk humans Infection lack of randomization limitations MERS MERS-CoV middle MOST objective other treatments outbreak outcomes Pandemics patient selection plasma preliminary trial randomized clinical trial randomized control trial Randomized control trials recipient Registered registry Research respiratory syndrome coronavirus sample sizes SARS-CoV SARS-CoV-2 searched severe disease short-lived Source steroid Still therapeutic option titres treat Treatment treatment for COVID-19 was performed World Health Organization
[DOI] 10.1016/j.cmi.2020.08.005 PMC 바로가기 [Article Type] Narrative Review

The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia

Original Research

Published on 2020-08-112023-05-31
Journal: Frontiers in Immunology [Category] Fulltext, 두창, 수두, 홍역,

[키워드] clinical trial combined immunodeficiency immunization MMR RMRP vaccination Varicella zoster virus
[DOI] 10.3389/fimmu.2020.02020 PMC 바로가기 [Article Type] Original Research

Emerging Therapeutic Modalities against COVID-19

Review

Published on 2020-08-082022-10-28
Journal: Pharmaceuticals [Category] COVID-19,

Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

Letter

Published on 2020-08-082022-10-29
Journal: Trials [Category] COVID-19, MERS,

[키워드] 1:1 absence Admission Alanine transaminase assigned Black seed Blinding block Breast feeding Chronic kidney disease chronic liver disease clinical trial clinically comparator computer-generated randomization conducted control group control groups COVID-19 COVID19 Date defined dialysis disease dissemination Efficacy element eligible patient exploratory glomerular filtration rate hospital Infection intensive care Jeddah King limit medication Mild Nigella Sativa no symptoms number objective Open-label outcome parallel-group participant Patient phytotherapy Pneumonia polymerase chain reaction Prospective protocol radiological randomisation randomised randomised controlled trial Randomly recruited renal respiratory Sample size SARS-CoV-2 Saudi Arabia Standard of care status Symptom symptomatic mild the patient throat swab transfer treat Treatment Trial Two-arm university upper respiratory tract website written Informed Consent
[DOI] 10.1186/s13063-020-04647-x PMC 바로가기 [Article Type] Letter